| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 04/22/2014 | US8703930 Cancer cell-specific apoptosis-inducing agents that target chromosome stabilization-associated genes |
| 04/22/2014 | US8703920 Fully human antibodies against N-cadherin |
| 04/22/2014 | US8703917 Epidermal growth factor receptor variants and pharmaceutical compositions thereof |
| 04/22/2014 | US8703914 Heterologous expression of neisserial proteins |
| 04/22/2014 | US8703913 Sensor |
| 04/22/2014 | US8703911 Cytokine receptor peptides, compositions thereof and methods thereof |
| 04/22/2014 | US8703908 Expression and export of angiogenesis inhibitors as immunofusins |
| 04/22/2014 | US8703907 Controlled drug release from dendrimers |
| 04/22/2014 | US8703906 Disulfide-linked polyethyleneglycol/peptide conjugates for the transfection of nucleic acids |
| 04/22/2014 | US8703904 Hydrogels and methods for producing and using the same |
| 04/22/2014 | US8703903 Method for quantification of allergens |
| 04/22/2014 | US8703750 Mixtures and methods for the induction of resistance in plants |
| 04/22/2014 | US8703729 Mixture comprising an inhibitor or suppressor of a gene and a molecule binding to an expression product of that gene |
| 04/22/2014 | US8703718 Methods for treating juvenile rheumatoid arthritis by administering a soluble CTLA4 molecule |
| 04/22/2014 | US8703717 Growth hormone polypeptides and methods of making and using same |
| 04/22/2014 | US8703715 Methods for inhibiting growth of prolactin-responsive cancer cells with cyclosporine a or other cyclophilin inhibitors |
| 04/22/2014 | US8703714 Monomethylvaline compounds capable of conjugation to ligands |
| 04/22/2014 | US8703713 Combination therapy for pancreatic cancer using an antigenic peptide and chemotherapeutic agent |
| 04/22/2014 | US8703711 Ninjurin-1 modulation and uses thereof |
| 04/22/2014 | US8703710 Method of reducing cell death by administering a paracrine factor of a mesenchymal stem cell |
| 04/22/2014 | US8703709 Methods, compositions and articles of manufacture for contributing to the treatment of solid tumors |
| 04/22/2014 | US8703708 Agents and methods for tissue repair and regeneration |
| 04/22/2014 | US8703707 Nucleobindin I variant protein compositions and methods of use |
| 04/22/2014 | US8703706 Closed container comprising an activated factor VII polypeptide, processes for the preparation of the same, and a kit and a method for use of the kit |
| 04/22/2014 | US8703705 Modified factor VIII peptides |
| 04/22/2014 | US8703704 Method for growing, restoring and regenerating hair |
| 04/22/2014 | US8703703 MCPIP as wound therapy |
| 04/22/2014 | US8703702 Therapeutically active α-MSH analogues |
| 04/22/2014 | US8703701 Glucagon/GLP-1 receptor co-agonists |
| 04/22/2014 | US8703700 Bimacrocylic HCV NS3 protease inhibitors |
| 04/22/2014 | US8703699 Lactoferrin |
| 04/22/2014 | US8703698 Compositions and methods for treating atherosclerosis |
| 04/22/2014 | US8703696 Dipeptoid prodrugs and the use thereof |
| 04/22/2014 | US8703695 Biologically active peptides and their new uses |
| 04/22/2014 | US8703694 Methods for increasing thermogenic adipocytes |
| 04/22/2014 | US8703693 Adrenomedullin and adrenomedullin binding protein for ischemia/reperfusion treatment |
| 04/22/2014 | US8703503 Methods and compositions for inhibition of BCL6 repression |
| 04/22/2014 | US8703474 Flavor compound-producing yeast strains |
| 04/22/2014 | US8703471 System and method for the production of recombinant glycosylated proteins in a prokaryotic host |
| 04/22/2014 | US8703429 Composition exhibiting a von Willebrand Factor (vWF) protease activity comprising a polypeptide chain with the amino acid sequence AAGGILHLELLV |
| 04/22/2014 | US8703426 Composition exhibiting a von Willebrand Factor (vWF) protease activity with the amino acid sequence AAGGILHLELLV |
| 04/22/2014 | US8703195 Method for solubilising, dispersing and stabilising of substances, products manufactured according to the method as well as the use thereof |
| 04/22/2014 | US8703174 Joint preserving nutritional vitamin, mineral and herbal pet supplement |
| 04/22/2014 | US8703169 Implantable device having a coating comprising carrageenan and a biostable polymer |
| 04/22/2014 | US8703155 Method of stabilizing reduced coenzyme q10 |
| 04/22/2014 | US8703152 Methods of treating inflammatory intestinal disease and managing symptoms thereof |
| 04/22/2014 | US8703145 Materials and methods for immunizing against FIV infection |
| 04/22/2014 | US8703144 Allergen peptide fragments and use thereof for treatment of dust mite allergies |
| 04/22/2014 | US8703143 Antibodies of the ED-B domain of fibronectin, their construction and uses |
| 04/22/2014 | US8703141 Method for treating Crohn's disease by administering an anti-IL-12 antibody |
| 04/22/2014 | US8703133 Antibody variants |
| 04/22/2014 | US8703128 Methods of modulating TGFβ signaling |
| 04/22/2014 | US8703117 Cross-linked compositions |
| 04/22/2014 | US8703112 Low odor coating compositions and paints |
| 04/22/2014 | US8703096 Beta-amyloid PET imaging agents |
| 04/22/2014 | CA2751655C Proteins encoded by polynucleic acids of porcine reproductive and respiratory syndrome virus (prrsv) |
| 04/22/2014 | CA2751187C Use of (-)(3-trihalomethylphenoxy)(4-halophenyl)acetic acid and derivatives thereof for treatment of hyperuricemia |
| 04/22/2014 | CA2687890C Isolated milk or whey cationic fraction for treating a microbial infection |
| 04/22/2014 | CA2658949C Inhibition of marcks-mediated degranulation by marcks n-terminal pepetides in treating inflammation |
| 04/22/2014 | CA2598044C Cosmetic use of at least one natural ac-n-ser-asp-lys-pro-tetrapeptide or one of its analogues as agent for slowing down loss of hair and/or stimulating hair growth |
| 04/22/2014 | CA2572015C Fc-interferon-beta fusion proteins |
| 04/22/2014 | CA2561530C Therapeutic or prophylactic agent for arthritis |
| 04/22/2014 | CA2548135C Synthetic hla binding peptide analogues and uses thereof |
| 04/22/2014 | CA2546287C Reduction of dermal scarring |
| 04/22/2014 | CA2534897C Process of making flowable hemostatic compositions and devices containing such compositions |
| 04/22/2014 | CA2527795C Methods for synthesizing conformationally constrained peptides, peptidometics and the use thereof as synthetic vaccines |
| 04/22/2014 | CA2507125C Ena nucleic acid pharmaceuticals capable of modifying splicing of mrna precursors |
| 04/22/2014 | CA2398998C Cd40-binding apc-activating molecules |
| 04/22/2014 | CA2345209C Antisense modulation of integrin .alpha.4 expression |
| 04/17/2014 | WO2014059385A1 Methods and small molecule therapeutics comprising fused elps |
| 04/17/2014 | WO2014059384A2 ICAM-1 TARGETING ELPs |
| 04/17/2014 | WO2014059332A1 An attenuated ehec and clostridial toxins tcda and tcdb based vaccine for clostridium difficil associated disease (cdad) |
| 04/17/2014 | WO2014059255A1 Transcription activator-like effector (tale) - lysine-specific demethylase 1 (lsd1) fusion proteins |
| 04/17/2014 | WO2014059213A1 NOVEL α4ß7 PEPTIDE DIMER ANTAGONISTS |
| 04/17/2014 | WO2014059197A1 Methods and compositions for diagnosing and treating hyposmia |
| 04/17/2014 | WO2014059196A2 Diagnosis and treatment of sma and smn deficiency |
| 04/17/2014 | WO2014059183A2 Methods and automated systems for testing, optimization, and analysis that preserve continuity in identities and status of users who access remote information from different contexts |
| 04/17/2014 | WO2014059174A1 Use of relaxin to treat atrial fibrillation |
| 04/17/2014 | WO2014059115A1 Compositions and methods for diagnosis and treatment of neurological disease |
| 04/17/2014 | WO2014059068A1 Methods for the treatment and prevention of osteoporosis and bone-related disorders |
| 04/17/2014 | WO2014059029A1 Treatment of age-related and mitochondrial diseases by inhibition of hif-1 alpha function |
| 04/17/2014 | WO2014058915A2 Therapies based on control of regulatory t cell stability and function via a neuropilin-1:semaphorin axis |
| 04/17/2014 | WO2014058866A2 Treatment of amyotrophic lateral sclerosis |
| 04/17/2014 | WO2014058786A2 Prevention of kidney injury or disease |
| 04/17/2014 | WO2014058343A1 Osteogenic bioresorbable material for the replacement of bone defects and method for producing same |
| 04/17/2014 | WO2014058329A1 Compositions based on hypophyseal hormones for adding to infusion fluids |
| 04/17/2014 | WO2014058114A1 Composition, containing cis-cyclo(l-leu-l-pro) or cis-cyclo(l-phe-l-pro), for use as an antimicrobial and antiviral agent, and preparation method therefor |
| 04/17/2014 | WO2014057997A1 Reprogramming peptide and use thereof |
| 04/17/2014 | WO2014057484A1 Peptides for the treatment of neurodegenerative diseases |
| 04/17/2014 | WO2014057108A1 Serum amyloid p-component as a therapeutic agent or biomarker |
| 04/17/2014 | WO2014057092A1 Novel use of a composition comprising oxytocin |
| 04/17/2014 | WO2014057069A1 Liquid pharmaceutical composition of factor vii polypeptide |
| 04/17/2014 | WO2014057068A1 Liquid pharmaceutical composition of factor vii polypeptide |
| 04/17/2014 | WO2014056954A1 Macrocyclic ketoamide immunoproteasome inhibitors |
| 04/17/2014 | WO2014056872A1 Exendin-4 derivatives as dual glp1/glucagon agonists |
| 04/17/2014 | WO2014056422A1 hnRNP A2* PROTEIN, NUCLEIC ACID FOR CODING PROTEIN AND USE THEREOF |
| 04/17/2014 | WO2014056298A1 Kit for treating brain injury or stroke |
| 04/17/2014 | WO2014056121A1 Compositions and methods for treating heart failure in diabetic patients |
| 04/17/2014 | WO2014056039A1 Antimicrobial peptides modified for mammalian cell recognition and/or adhesion |
| 04/17/2014 | WO2014056026A1 Improved process for purifying growth factors from milk and products thereof |